Exscientia plc is a company utilizing Generative AI to revolutionize drug research and development, with a focus on accelerating approvals and reducing time to market. Despite a recent dip in stock price due to interest rate concerns, the company’s strong technology platform and potential for profitability make it a promising investment opportunity.
